VISCHER advised Oberland Capital Management LLC on its financing agreement with the Helsinn Group. Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing in the global healthcare industry and specializing in flexible investment structures customized to meet the specific needs of its transaction partners. The Helsinn Group is a fully integrated, global biopharma group with a track record of over 40 years of commercial execution and a strong focus in oncology and rare diseases.

VISCHER acted as Swiss legal advisor to Oberland Capital in this transaction. The team was led by Adrian Dörig (Partner, Banking & Finance) and included Christoph Niederer (Partner, Tax), Jana Essebier (Partner, Banking & Finance), Jonas Gassmann (Counsel, IP), Seraina Jenny-Tsering (Managing Associate, Banking & Finance), Christian Schneiter (Senior Associate, Banking & Finance), Patrik Fisch (Senior Associate, Tax), Livia Camenisch (Associate, IP) and Dorothea Wirth (Junior Associate, Banking & Finance).